Stem Cell Banking Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to stem cell banking market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Stem Cell Banking Market News

  • In February 2023, Cordlife Group Limited, made an announcement about the launch of their peripheral blood stem cell processing and storage services. It will extend their banking services.
  • In March 2023, Sinfonica and UK Stem Cell Bank collaborated. The objectives were to analyze CellQualia Intelligent Cell Processing System in the NIBSC lab.
  • In May 2024, Abu Dhabi Biobank opened, launching the area’s biggest hybrid cord blood bank.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Stem Cell Banking Market size was valued at USD 9.85 Billion in 2023 and is poised to grow from USD 11.65 Billion in 2024 to USD 22.06 Billion by 2032, growing at a CAGR of 18.30% during the forecast period (2025-2032).

The key companies are strengthening the growth of the market with a multifaceted method. These companies are investing massively in advanced research and development, boosting advancement in stem cell preservation and analysis methods. They are continuously improving the quality and availability of stored stem cells, by incorporating confidence in their clients and medical sector. These businesses are also focusing on collaboration with research facilities, pharmaceutical firms, and medical providers. These collaborative initiatives are also increasing advancements of the cell-based therapies, extending their applications and increasing the demand for banking services. 'Cordlife (Singapore)  ', 'Cryo-Cell International (US)  ', 'LifeCell International (India)  ', 'StemCyte (US)  ', 'Global Cord Blood (Hong Kong)  ', 'Smart Cells International (UK)  ', 'Vita34 (Germany)  ', 'CryoHoldco (US)  ', 'Cellerant Therapeutics, Inc. (US)  ', 'StemCell Technologies Inc. (Canada)  ', 'Regenexx (US)  ', 'Athersys, Inc. (US)  ', 'Mesoblast Limited (Australia)  ', 'Cytori Therapeutics, Inc. (US)  ', 'OrthoGenics (US)  ', 'Panthera Biopartners (UK)  ', 'Stemson Therapeutics (US)  ', 'Lonza Group AG (Switzerland)  ', 'Macopharma (France)  ', 'Cure Cell (Turkey)  ', 'LifeBankUSA (US)  ', 'Biolife Plasma Services, LLC (US)  ', 'NexImmune, Inc. (US)'

In recent times, the stem cell market is moving towards adult stem cells, especially the ones that are manufactured from bone marrow or adipose tissue. These cells offer easy accessibility and ethically acceptable substitute to embryonic stem cells. Furthermore, advancements in minimally invasive gathering processes like utilizing a needle for extracting bone marrow, are improving the patient experience and increase popularity of stem cell banking.

Increasing Expansion Hematopoietic Stem Cell Transplantation: HSCT is a popular treatment utilized for blood malignancies and some genetic illnesses also uses stem cells. These growing success rates and increasing HSCT operations usage directly influence the stem cell banking sector. With the increasing usage of HSCT, the demand for easily available stem cell sources either from personal bank or registries is also growing rapidly.

Based on region, North America is dominating the stem cell banking market with the largest share. The market of North America for stem cell banking holds a massive portion of the medical and biotechnology industry. This region is one of the biggest markets for stem cell banking, particularly in United States and Canada. The rising prevalence of chronic diseases and increasing awareness of the possible advantages of stem cell therapies have increased the market's growth. As stem cells are a type of biological insurance, many families are trying to collect stem cells from the umbilical cord blood and tissues doing birth. It is expected that future medical advancements can benefit their offspring and family members.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Stem Cell Banking Market
Stem Cell Banking Market

Report ID: SQMIG35H2294

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE